2 Result: Alvotech
Alvotech, Teva, JNJ Settle on AVT04; Teck Resources Evaluating Glencore Proposal
June 12th, 2023
Alvotech (Nasdaq: ALVO) and an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced a settlement and license agreement with Johnson & Johnson (NYSE: JNJ) concerning AVT04, Alvotech's proposed biosimilar to Stelara (ustekinumab. Read more
The Week On The Horizon: Brady Corporation, Canadian Solar, Canada Goose, Alvotech
May 14th, 2023
On Thursday, May 18, investors and analysts will be keeping a close eye on several notable companies set to report their financial results. Brady Corporation (NYSE: BRC) is expected to release its fiscal 2023 third quarter financial results . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login